公开(公告)号：US11896043B2

公开(公告)日：2024-02-13

申请号：US17476131

申请日：2021-09-15

Applicant: DAICEL CORPORATION

Inventor： Tadashi Takeuchi ,  Eiji Miyauchi ,  Shu Shimamoto ,  Akinobu Matsuyama ,  Hiroshi Ohno

IPC: A23L33/24 ,  A61K31/717 ,  G06F17/18

CPC classification number: A23L33/24 ,  A61K31/717 ,  G06F17/18

Abstract: Object of the present invention is to provide an intestinal immune-enhancing agent that can sufficiently increase IgA in the intestinal tract with a low dose while maintaining an increased amount of IgA for an extended period of time. Provided is an intestinal immune-enhancing agent containing a cellulose acetate that has a total degree of acetyl substitution from 0.4 to 1.1.

公开(公告)号：US12220426B2

公开(公告)日：2025-02-11

申请号：US17284927

申请日：2019-10-24

Applicant: DAICEL CORPORATION

Inventor： Hiroshi Ohno ,  Tadashi Takeuchi ,  Shu Shimamoto ,  Shuuji Yoshioka ,  Eiji Miyauchi ,  Hiroki Negishi

IPC: A61K31/717 ,  A23L33/10 ,  A61P35/00

Abstract: An object is to provide a Th1-increasing agent that can reduce constraints on storage conditions and feeding form and sufficiently increase Th1 at lower doses. A Th1-increasing agent containing a cellulose derivative as an active ingredient, the cellulose derivative having a degree of butyryl substitution of 0.3 or greater and 2.6 or less, and a total degree of substitution of 0.5 or greater and 2.8 or less.